Ticker
INBXCompany Name
INHIBRX BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -140.13M | -10009.5% | $ 1.4M |
3/31/2025 | $ -168.75M | -84376.5% | $ 200K |
12/31/2024 | $ -197.01M | -98503% | $ 200K |
12/31/2023 | $ -197.9M | -10994.56% | $ 1.8M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for INHIBRX BIOSCIENCES INC is calculated as follows: FCF [ $ -197.9M ] / Revenues [ $ 1.8M ]
(=) FCF % [ -10994.56% ]
Minimum
Dec 31, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |